Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Showing 1 to 3 of 3

TitleReference numberPublishedLast updated
Tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 25 years and underTA975
Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies (terminated appraisal)TA933
Tisagenlecleucel for treating follicular lymphoma after 2 or more therapies (terminated appraisal)TA842

Results per page

  1. 10
  2. 25
  3. 50
  4. All